Hopkins researchers find tourette drug has unexpected effect

A new study by Johns Hopkins Children's Center neurologists suggests that baclofen, a drug long thought to be effective in reducing the vocal and motor tics associated with Tourette syndrome, improves a patient's overall sense of well-being but does not significantly reduce tics.

"One of our conclusions is that baclofen helps as a treatment for Tourette syndrome, but it appears to improve something other than tics," says pediatric neurologist Harvey Singer, M.D., the report's lead author. "We originally thought baclofen would diminish patients' vocal and muscular tics but found, instead, that it's more useful in making patients feel less impaired by their tics."

In the first double-blind study of baclofen in patients with Tourette syndrome (TS), the research team scored the severity of TS symptoms of nine children between the ages of 8 and 14 years by using two standard indices, the Clinical Global Impression and Yale Global Tic Severity scales. Their report, which appears in this month's Neurology, reveals that patients in the study said they were less "impaired" while using the drug, even though phonic and motor tics did not significantly diminish in frequency.

While baclofen caused no major side effects among children in the placebo-controlled, crossover study, Singer says the drug may not be the most effective medication for suppressing tics in children with TS.

"Learning which kinds of drugs suppress tics the best may enable us to develop more effective treatments in the future," Singer says. "Testing medications in a rigorous setting represents the first step in identifying better therapies for TS."

The number of TS drugs doctors have to choose from may be quite large, since the underlying mechanism for tics may involve several brain chemicals, or neurotransmitters. As a "tier-1" drug, baclofen does not cause severe or long-term side effects, but its effect in reducing tics may be

Contact: David Bricker
Johns Hopkins Medical Institutions

Page: 1 2

Related biology news :

1. Hopkins scientists use blood proteins to detect ovarian cancer
2. Hopkins to found first center for comprehensive study of epigenetics
3. Hopkins scientists overcome main obstacle to making tons of short, drug-like proteins
4. Hopkins Marine Station honored by the American Society for Microbiology
5. Johns Hopkins gene hunters pinpoint new cancer gene target
6. Hopkins researchers identify transplantation antigens among Sioux Indians
7. Hopkins researchers discover how nitric oxide prevents blood vessel inflammation
8. Hopkins is first US institution to obtain powerful genotyping system
9. Dr. Robot tested at Hopkins
10. From Hopkins: Children may outgrow peanut allergies
11. OXiGENE announces launch of ophthalmic clinical trial at The Johns Hopkins School of Medicine

Post Your Comments:

(Date:11/6/2019)... ARBOR, Mich. (PRWEB) , ... November 06, 2019 ... ... Mastermind® version 2.0 today. The Genomic Search Engine now includes the ... new functionality will further accelerate diagnosis of patients with genetic and rare diseases. ...
(Date:11/2/2019)... , ... October 31, 2019 , ... In this podcast, ... a successful career in research and consulting. , The Beyond the Lab Podcast is ... feature interviews from alumni who have jobs in the biomedical field — and in ...
(Date:10/30/2019)... ... October 30, 2019 , ... ... Credit Knowledge Center in which participants will learn about precision agriculture tools used ... to these technologies. , Participants will have the opportunity to visit Virginia ...
Breaking Biology News(10 mins):
(Date:11/5/2019)... N.J. (PRWEB) , ... November ... ... global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... its next-generation cell line development technology, GPEx® Boost. The technology enhances Catalent’s ...
(Date:11/2/2019)... ... October 31, 2019 , ... Join Patrick Raber, ... live webinar on Friday, November 15, 2019 at 1pm EST to ... science of profiling T-cell receptors (TCRs) and B-cell receptors (BCRs), has been widely ...
(Date:10/29/2019)... ... ... CaroGen Corporation , a biotechnology company, today announced three distinguished additions ... Wands, MD, of Brown University , Dr. Steve Projan, PhD, FAAM, formerly ... of Wayne State University, formerly a professor at Yale University School of Medicine ...
(Date:10/22/2019)... , ... October 22, 2019 , ... nQ Medical, Inc. ... School’s 2019 Most Fundable Companies List which was announced at a showcase event yesterday ... million in annual revenue, strong business plans, and impressive near-term growth projections to be ...
Breaking Biology Technology:
Cached News: